-Stephen R Marder Researcher Activity Profile

Research Author Detailed Information 

Stephen R Marder Publication Rate By Year

Stephen R Marder has published 3 paper(s) in 1994, 1 paper(s) in 1999, 1 paper(s) in 2001, 2 paper(s) in 2002, 1 paper(s) in 2003, 1 paper(s) in 2004, 4 paper(s) in 2005, 3 paper(s) in 2006, 17 paper(s) in 2007, 11 paper(s) in 2008, for a total of 44 research publications in total.

Stephen R Sr Marder Author Information

LAST NAME: marder

FIRST NAME: Stephen R

INITIALS: sr

AFFILIATION:

Papers

Stephen R Marder's Publication Record

1. Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients. Year Published: 2007
Veterans Administration Greater Los Angeles Healthcare System, UCLA, Los Angeles, CA, USA. kannan@ucla.edu
2. New paradigms for treatment development. Year Published: 2007
National Institute of Mental Health, Bethesda, MD, USA.
3. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Year Published: 2007
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA. jkwynn@ucla.edu
4. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Year Published: 2007
Department of Psychology, California State University, 18111 Nordhoff St., Northridge, CA 91330-8255, USA. mark.sergi@csun.edu
5. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Year Published: 2007
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.
6. Chronic restlessness with antipsychotics. Year Published: 2007
San Diego VA Mental Illness Research, Education, and Clinical Center, CA, USA. ibratti@mednet.ucla.edu
7. Photorefractive polymers sensitized by two-photon absorption. Year Published: 2007
8. New paradigms for treatment development. Year Published: 2007
National Institute of Mental Health, Bethesda, MD, USA.
9. Chronic restlessness with antipsychotics. Year Published: 2007
San Diego VA Mental Illness Research, Education, and Clinical Center, CA, USA. ibratti@mednet.ucla.edu
10. The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2006 update. Year Published: 2007
Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA. mooret3@uthscsa.edu
11. Transillumination imaging through scattering media by use of photorefractive polymers. Year Published: 2007
12. Newer antipsychotics and the differences between clinical experiences and clinical trials. Year Published: 2007
13. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. Year Published: 2007
Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA. mooret3@uthscsa.edu
14. Bis[bis-(4-alkoxyphenyl)amino] derivatives of dithienylethene, bithiophene, dithienothiophene and dithienopyrrole: palladium-catalysed synthesis and highly delocalised radical cations. Year Published: 2007
School of Chemistry and Biochemistry and Center for Organic Photonics and Electronics, Georgia Institute of Technology, Atlanta, GA 30332-0400, USA.
15. Two-photon absorption and broadband optical limiting with bis-donor stilbenes. Year Published: 2008
16. Polymerized bicontinuous cubic nanoparticles (cubosomes) from a reactive monoacylglycerol. Year Published: 2002
C. S. Marvel Laboratories, Department of Chemistry, University of Arizona, Tucson 85721, USA.
17. Ultrabright supramolecular beacons based on the self-assembly of two-photon chromophores on metal nanoparticles. Year Published: 2003
Department of Chemistry, University of Arizona, Tucson 85721-0041, USA.
18. Delocalization in platinum-alkynyl systems: a metal-bridged organic mixed-valence compound. Year Published: 2004
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
19. Two-photon absorption at telecommunications wavelengths in a dipolar chromophore with a pyrrole auxiliary donor and thiazole auxiliary acceptor. Year Published: 2005
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, 30332-0400, USA.
20. Strong, low-energy two-photon absorption in extended amine-terminated cyano-substituted phenylenevinylene oligomers. Year Published: 2005
School of Chemistry and Biochemistry and Center for Organic Photonics and Electronics, Georgia Institute of Technology, Atlanta, GA 30332, USA.
21. High charge-carrier mobility in an amorphous hexaazatrinaphthylene derivative. Year Published: 2005
Center for Organic Photonics and Electronics, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.
22. Ultrafast energy migration in chromophore shell-metal nanoparticle assemblies. Year Published: 2006
Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.
23. Bisdioxaborine polymethines with large third-order nonlinearities for all-optical signal processing. Year Published: 2006
School of Chemistry and Biochemistry and Center for Organic Photonics and Electronics, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, USA.
24. Extended squaraine dyes with large two-photon absorption cross-sections. Year Published: 2006
School of Chemistry and Biochemistry and Center for Organic Photonics and Electronics, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, USA.
25. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. Year Published: 2007
Veteran's Affairs Veteran's Integrated Service Networks 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, California 90073, USA. marder@ucla.edu
26. Sex, race, and smoking impact olanzapine exposure. Year Published: 2008
PharmD, University of Pittsburgh, School of Pharmacy, 805 Salk Hall, 3501 Terrace St, Pittsburgh, PA 15261; e-mail: rrb47@pitt.edu.
27. Selective corticostriatal dysfunction in schizophrenia: Examination of motor and cognitive skill learning. Year Published: 2008
Department of Psychology, University of California.
28. Newer antipsychotics and the differences between clinical experiences and clinical trials. Interview by Norman Sussman, MD. Year Published: 2007
29. Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study. Year Published: 2008
Semel Institute for Neuroscience and Human Behavior, UCLA, 300 Medical Plaza, Rm. 2263, Los Angeles, CA 90095-6968. mgreen@ucla.edu.
30. The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization. Year Published: 2008
VA Greater Los Angeles Healthcare Center, MIRECC 210 A, Bldg. 210, Rm. 116, 11301 Wilshire Blvd., Los Angeles 90073. rkern@ucla.edu.
31. The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity. Year Published: 2008
UCLA Semel Institute for Neuroscience and Human Behavior, 300 Medical Plaza, Rm. 2251, Los Angeles, CA 90095-6968. keithn@ucla.edu.
32. Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implications. Year Published: 1994
College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
33. An approach to treatment resistance in schizophrenia. Year Published: 1999
West Los Angeles VA Medical Center, CA 90073, USA.
34. In vivo MR evaluation of age-related increases in brain iron. Year Published: 1994
Research Service, West Los Angeles VA Medical Center, CA 90073.
35. Integrating pharmacological and psychosocial treatments for schizophrenia. Year Published: 2001
VISN 22 Mental Illness Research, Education, and Clinical Center, the West Los Angeles Veterans Affairs Medical Center, CA 90073, USA.
36. Helical CT with sagittal and coronal reconstructions: accuracy for detection of diaphragmatic injury. Year Published: 2002
Department of Radiology, SS Annunziata Hospital, University of G. d'Annunzio, Via P. Valignani 1, Chieti 66100, Italy.
37. The role of dosage and plasma levels in neuroleptic relapse prevention. Year Published: 1994
West Los Angeles Veterans Affairs Medical Center, Brentwood Division, CA 90073.
38. Subjective experiences on antipsychotic medications: synthesis and conclusions. Year Published: 2005
VISN 22 Mental Illness Research, Education, and Clinical Center (MIRECC), West Los Angeles Veterans Affairs Medical Center, and Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, CA 90073, USA. marder@ucla.edu
39. Unconscious emotional reasoning and the therapeutic misconception. Year Published: 2008
NYU Child Study Center, 577 First Ave., New York, New York 10016, USA. ACharuvastra@gmail.com
40. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Year Published: 2008
Semel Institute for Neuroscience and Human Behavior, UCLA, 300 Medical Plaza, Rm. 2263, Los Angeles, CA 90095-6968, USA. mgreen@ucla.edu
41. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Year Published: 2008
Department of Psychology, Geffen School of Medicine, University of California, Los Angeles CA 90073, USA. rkern@ucla.edu
42. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Year Published: 2008
Department of Psychology, UCLA Semel Institute for Neuroscience and Human Behavior, 300 Medical Plaza, Rm. 2251, Los Angeles, CA 90095-6968, USA. keithn@ucla.edu
43. It is time to take a stand for medical research and against terrorism targeting medical scientists. Year Published: 2008
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. john.krystal@yale.edu
44. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. Year Published: 2007
Veteran's Affairs Veteran's Integrated Service Networks 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, California 90073, USA. marder@ucla.edu